申请人:Gross Laird Jonathan
公开号:US20050261347A1
公开(公告)日:2005-11-24
Compounds of formula 2 or pharmaceutically acceptable salts thereof are provided:
wherein each of R
1a
, R
2a
, R
3a
, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia.
提供了公式2或其药用盐的化合物:其中R1a、R2a、R3a、Ar、y和m的定义如下,它们是大脑5-羟色胺受体2C亚型的激动剂或部分激动剂。这些化合物及含有这些化合物的组合物用于治疗多种中枢神经系统疾病,如精神分裂症。